Pardes Biosciences, Inc.
https://www.pardesbio.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pardes Biosciences, Inc.
Finance Watch: Amylyx, CinCor And Vigil Ready The First Biopharma IPOs Of 2022
Bookmark
-
Analysis
Public Company Edition: Mergers with special purpose acquisition corporations also continue to take companies public, with three new SPAC offerings in late 2021. Also, Xeris raised $30m in a private placement of stock to support its recently approved drug and Sirnaomics went public in Hong Kong.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
Advertisement
Advertisement